ATH 0.00% 0.5¢ alterity therapeutics limited

The PBT2 deal is depending longer than at least I ever thought,...

  1. 2,758 Posts.
    lightbulb Created with Sketch. 960
    The PBT2 deal is depending longer than at least I ever thought, now over 6 months after the Queensland agreement. The purpose and the goal of the antibiotic-resistant fund have practically achieved by PBT2. It looks like PBT2 helps more than 2-4 old antibiotics to kill again the earlier resistant bacteria.

    This may be a problem and the reason for this delay, no need for the whole organization, at least for some 10 years. The 1 billion dollars the fund has needs to give to ATH to get PBT2 to the market for this purpose and save 700.000 lives. With PBT2 there will be many more than 2-4 drugs against antibiotic-resistant bacteria, but nothing happens without PBT2.

    However, it is obvious that the newly founded organization will not give all its money to ATH and it wants not to stop working even the goal has been achieved. PBT2 is a disruptive drug and perhaps so disruptive that the deal cannot be made with this fund. At least a disruptive and not traditional deal needs to be invented.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.5¢
Change
0.000(0.00%)
Mkt cap ! $26.22M
Open High Low Value Volume
0.5¢ 0.6¢ 0.5¢ $17.30K 3.445M

Buyers (Bids)

No. Vol. Price($)
48 42714645 0.5¢
 

Sellers (Offers)

Price($) Vol. No.
0.6¢ 22897179 17
View Market Depth
Last trade - 16.10pm 13/05/2024 (20 minute delay) ?
Last
0.6¢
  Change
0.000 ( 10.0 %)
Open High Low Volume
0.6¢ 0.6¢ 0.5¢ 1250891
Last updated 15.59pm 13/05/2024 ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.